Sunshine Lake Pharma Co., Ltd. (HKG:6887)

Sunshine Lake Pharma Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 29, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	26,411	8,412	8,351	5,720	5,368	7,770
Market Cap Growth	232.74%	0.74%	46.00%	6.56%	-30.92%	-60.53%
Enterprise Value	27,291	9,289	9,299	9,130	7,738	7,962
Last Close Price	45.80	32.84	32.60	22.33	20.95	30.33
PE Ratio	20.68	16.38	3.80	66.05	-	7.79
PS Ratio	6.66	2.12	1.20	1.35	4.79	2.79
PB Ratio	2.92	0.93	0.96	0.83	0.73	1.28
P/TBV Ratio	3.40	1.08	1.17	1.71	1.19	2.00
P/FCF Ratio	-	-	5.70	4.48	-	21.43
P/OCF Ratio	277.55	88.41	4.53	2.98	-	5.04
EV/Sales Ratio	6.89	2.34	1.34	2.16	6.90	2.86
EV/EBITDA Ratio	24.08	8.29	2.66	11.68	-	7.06
EV/EBIT Ratio	38.32	13.05	3.03	25.02	-	8.04
EV/FCF Ratio	-29.18	-	6.35	7.15	-	21.96
Debt / Equity Ratio	0.26	0.26	0.33	0.63	0.53	0.59
Debt / EBITDA Ratio	2.10	2.10	0.82	5.46	-	3.15
Debt / FCF Ratio	-	-	1.96	3.38	-	9.86
Asset Turnover	0.30	0.30	0.51	0.33	0.09	0.24
Inventory Turnover	1.76	1.76	3.62	3.02	1.31	1.20
Quick Ratio	1.29	1.29	0.87	0.46	1.36	0.64
Current Ratio	1.77	1.77	1.40	1.01	1.66	0.78
Return on Equity (ROE)	5.87%	5.87%	26.50%	0.81%	-10.57%	17.22%
Return on Assets (ROA)	3.32%	3.32%	14.16%	1.80%	-2.85%	5.35%
Return on Capital (ROIC)	3.93%	3.93%	17.07%	2.11%	-3.30%	6.61%
Return on Capital Employed (ROCE)	7.00%	7.00%	33.20%	4.60%	-	15.40%
Earnings Yield	1.94%	6.11%	26.29%	1.51%	-13.44%	12.83%
FCF Yield	-3.54%	-11.12%	17.54%	22.33%	-23.30%	4.67%
Dividend Yield	12.37%	-	-	-	-	1.49%
Payout Ratio	-	-	-	-	-	26.21%
Buyback Yield / Dilution	-	-	-	-	20.42%	-9.51%
Total Shareholder Return	12.37%	-	-	-	20.42%	-8.03%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.